Cargando…

Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis

Breast cancer (BC) ranks first in morbidity and mortality among female malignant tumors worldwide. This study is aimed at clarifying clinical value of contrast-enhanced ultrasound (CEUS) in the diagnosis and differentiation of BC. A total of 108 BC patients admitted to our hospital from January 2019...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yingying, Xu, Ming, Ren, Yi, He, Lili, Chen, Jiejie, Sun, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467778/
https://www.ncbi.nlm.nih.gov/pubmed/36105240
http://dx.doi.org/10.1155/2022/2017026
_version_ 1784788265251897344
author Yuan, Yingying
Xu, Ming
Ren, Yi
He, Lili
Chen, Jiejie
Sun, Li
author_facet Yuan, Yingying
Xu, Ming
Ren, Yi
He, Lili
Chen, Jiejie
Sun, Li
author_sort Yuan, Yingying
collection PubMed
description Breast cancer (BC) ranks first in morbidity and mortality among female malignant tumors worldwide. This study is aimed at clarifying clinical value of contrast-enhanced ultrasound (CEUS) in the diagnosis and differentiation of BC. A total of 108 BC patients admitted to our hospital from January 2019 to December 2021 were enrolled. All patients underwent conventional color Doppler ultrasound and CEUS imaging examination. All ultrasound images were analyzed by a senior (5+ years) sonographer. The lesion location, echo, size, and color Doppler flow imaging (CDFI) blood flow distribution of benign and malignant BC were assessed. The transverse and longitudinal diameters of malignant BC presented significant elevation compared with the control group (P < 0.05). CEUS is more reliable than conventional ultrasound in the differentiation of benign and malignant breast lesions, and CEUS has the best reliability. The comparison of CEUS observation indicators between benign and malignant groups demonstrated that CEUS enhancement patterns (time and intensity) and morphological features (lesion boundary, shape, range, homogeneity, and filling defect) presented statistical significance (P < 0.01). Irregular shape and range expansion were high-specificity indicators (all >90.00%); fast-forward, high enhancement, clear boundary, and range expansion were high-sensitivity (all >90.00%); and fast-forward, high enhancement, and clear boundary were low-specificity indicators (all <50.00%); moderate sensitivity is as follows: homogeneous enhancement and range expansion (all >80.00%). The area under curve of CEUS (0.735 ± 0.053) presented elevation relative to conventional ultrasound (0.901 ± 0.024), with statistical significance (Z1 = 2.462, P < 0.05). Relative to conventional ultrasound, the specificity and positive predictive value of CEUS presented elevation (P < 0.05). In conclusion, in the differentiation of benign and malignant breast lesions, CEUS has better diagnostic accuracy and reliability than conventional ultrasound. The diagnostic advantages of CEUS are to elevate the diagnostic specificity and positive predictive value and reduce the misdiagnosis rate.
format Online
Article
Text
id pubmed-9467778
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94677782022-09-13 Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis Yuan, Yingying Xu, Ming Ren, Yi He, Lili Chen, Jiejie Sun, Li Comput Math Methods Med Research Article Breast cancer (BC) ranks first in morbidity and mortality among female malignant tumors worldwide. This study is aimed at clarifying clinical value of contrast-enhanced ultrasound (CEUS) in the diagnosis and differentiation of BC. A total of 108 BC patients admitted to our hospital from January 2019 to December 2021 were enrolled. All patients underwent conventional color Doppler ultrasound and CEUS imaging examination. All ultrasound images were analyzed by a senior (5+ years) sonographer. The lesion location, echo, size, and color Doppler flow imaging (CDFI) blood flow distribution of benign and malignant BC were assessed. The transverse and longitudinal diameters of malignant BC presented significant elevation compared with the control group (P < 0.05). CEUS is more reliable than conventional ultrasound in the differentiation of benign and malignant breast lesions, and CEUS has the best reliability. The comparison of CEUS observation indicators between benign and malignant groups demonstrated that CEUS enhancement patterns (time and intensity) and morphological features (lesion boundary, shape, range, homogeneity, and filling defect) presented statistical significance (P < 0.01). Irregular shape and range expansion were high-specificity indicators (all >90.00%); fast-forward, high enhancement, clear boundary, and range expansion were high-sensitivity (all >90.00%); and fast-forward, high enhancement, and clear boundary were low-specificity indicators (all <50.00%); moderate sensitivity is as follows: homogeneous enhancement and range expansion (all >80.00%). The area under curve of CEUS (0.735 ± 0.053) presented elevation relative to conventional ultrasound (0.901 ± 0.024), with statistical significance (Z1 = 2.462, P < 0.05). Relative to conventional ultrasound, the specificity and positive predictive value of CEUS presented elevation (P < 0.05). In conclusion, in the differentiation of benign and malignant breast lesions, CEUS has better diagnostic accuracy and reliability than conventional ultrasound. The diagnostic advantages of CEUS are to elevate the diagnostic specificity and positive predictive value and reduce the misdiagnosis rate. Hindawi 2022-09-05 /pmc/articles/PMC9467778/ /pubmed/36105240 http://dx.doi.org/10.1155/2022/2017026 Text en Copyright © 2022 Yingying Yuan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yuan, Yingying
Xu, Ming
Ren, Yi
He, Lili
Chen, Jiejie
Sun, Li
Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis
title Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis
title_full Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis
title_fullStr Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis
title_full_unstemmed Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis
title_short Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis
title_sort clinical value of contrast-enhanced ultrasound in breast cancer diagnosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467778/
https://www.ncbi.nlm.nih.gov/pubmed/36105240
http://dx.doi.org/10.1155/2022/2017026
work_keys_str_mv AT yuanyingying clinicalvalueofcontrastenhancedultrasoundinbreastcancerdiagnosis
AT xuming clinicalvalueofcontrastenhancedultrasoundinbreastcancerdiagnosis
AT renyi clinicalvalueofcontrastenhancedultrasoundinbreastcancerdiagnosis
AT helili clinicalvalueofcontrastenhancedultrasoundinbreastcancerdiagnosis
AT chenjiejie clinicalvalueofcontrastenhancedultrasoundinbreastcancerdiagnosis
AT sunli clinicalvalueofcontrastenhancedultrasoundinbreastcancerdiagnosis